Systematic multiomics analysis and in vitro experiments suggest that ITGA5 could serve as a promising therapeutic target for ccRCC.
Che X, Tian X, Wang Z, Zhu S, Ye S, Wang Y, Chen Y, Huang Y, Anwaier A, Yao P, Chen Y, Wu K, Liu Y, Xu W, Zhang H, Ye D.
Che X, et al. Among authors: xu w.
Cancer Cell Int. 2024 Nov 5;24(1):363. doi: 10.1186/s12935-024-03546-4.
Cancer Cell Int. 2024.
PMID: 39501306
Free article.